Lipid lowering drugs (TBL) Flashcards

1
Q

Why do we treat lipid disorders, and what are the main consequences of these disorders?

A

Lipid disorders are treated to prevent adverse events. Lowering triglycerides can help avoid pancreatitis, while lowering cholesterol reduces the risk of cardiovascular disease. Cholesterol deposits in arterial walls can lead to conditions like heart attacks, strokes, and peripheral arterial disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the primary cause of atherosclerosis, and how does it relate to cholesterol?

A

Atherosclerosis is mainly caused by deposits of cholesterol in arterial walls. Cholesterol build-up can lead to arterial obstruction, potentially resulting in conditions like myocardial infarction (heart attack), stroke, and peripheral arterial disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does lowering cholesterol affect atherosclerotic disease progression and outcomes?

A

Numerous clinical trials have shown that lowering cholesterol can reduce the progression of atherosclerotic disease and improve long-term outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the drug classes discussed in this module for treating hyperlipidemia?

A

The drug classes discussed in this module include statins, bile acid sequestrants (resins), PCSK9 inhibitors, fibrates, niacin, and Omega-3 ethyl esters (fish oil).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are the discussed drugs organized based on their lipid-lowering effects?

A

The drugs are organized into two categories: those that lower cholesterol and those that lower triglycerides. Statins are the first-line agents for lowering cholesterol, while other drugs can have various effects on LDL cholesterol and triglycerides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why do lipids travel in the bloodstream as lipoproteins?

A

Lipids are too hydrophobic to travel in the bloodstream by themselves, so they are transported within lipoprotein particles. These particles also facilitate docking and regulate the movement of lipids within the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the role of chylomicrons, VLDL, LDL, and HDL in lipid metabolism?

A

Chylomicrons transport triglycerides from the diet to the liver. The liver processes these lipids and exports triglycerides in VLDL particles. Cholesterol travels from the liver to the periphery in LDL particles, while cholesterol returns to the liver from the periphery in the form of HDL particles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the liver’s role in lipid metabolism?

A

The liver serves as the central hub for lipid metabolism. It processes dietary lipids, exports triglycerides, synthesizes and exports cholesterol, and plays a vital role in overall lipid homeostasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the primary function of the liver regarding cholesterol, and why is it important to maintain a stable level of cholesterol?

A

The liver plays a central role in cholesterol homeostasis, ensuring a stable level of cholesterol. Cholesterol from the liver is used for various purposes in the body, including membrane formation, hormone production, and bile acid synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does the liver obtain cholesterol, and what is the balance between de novo synthesis and dietary intake?

A

The liver gets cholesterol from two main sources: de novo synthesis (50%) and dietary intake (50%), primarily through the uptake of LDL particles from the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the primary mechanism of action of statins, and how do they affect cholesterol levels in the liver?

A

Statins are HMG-CoA reductase inhibitors that block cholesterol synthesis in the liver. By inhibiting this step, they lead to an increase in the number of LDL receptors on the liver’s surface, resulting in greater uptake of LDL from the bloodstream and reduced cholesterol levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the desired outcome of statin treatment for cholesterol management?

A

The desired outcome of statin treatment is to reduce elevated cholesterol levels in the bloodstream, protecting various parts of the body from the harmful effects of excess cholesterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do statins affect the liver, and what is their mechanism of action?

A

Statins are HMG-CoA reductase inhibitors, and they block cholesterol synthesis in the liver. This leads to an increased number of LDL receptors on the liver’s surface, facilitating the uptake of LDL from the bloodstream to maintain stable cholesterol levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some potential adverse effects associated with statin use, and how do they impact patients?

A

Adverse effects of statins may include rhabdomyolysis, which leads to muscle pain and can result in dark urine due to myoglobin release. Liver dysfunction is another potential side effect, though routine monitoring frequency has been reduced. Statins should not be used during pregnancy and are excreted into breast milk. They can also slightly increase the risk of new-onset diabetes, but the cardiovascular benefits generally outweigh this risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of resins in lowering cholesterol, and how do they work in the body?

A

Resins, or bile acid sequestrants, work in the gut and bind to bile acids, preventing their reabsorption. This results in the loss of bile acids in the stool. To compensate for the loss, the body either synthesizes more cholesterol or takes up additional cholesterol from the bloodstream. Resins interfere with the recycling of bile acids, effectively reducing the cholesterol pool.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the impact of resins on triglyceride levels, and when should they not be used?

A

Resins can increase triglycerides and VLDL levels. Therefore, they should not be used in individuals with elevated triglyceride levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do resins, or bile acid sequestrants, work to lower cholesterol?

A

Resins work in the gut by binding to bile acids, preventing their reabsorption. This leads to the loss of bile acids in the stool. To compensate for the loss of bile acids, the body must either synthesize more cholesterol or take up additional cholesterol from the bloodstream, thereby reducing the cholesterol pool.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some side effects associated with taking resins?

A

Resins can cause unpleasant side effects such as constipation and a bloated feeling. They can also affect the absorption of other drugs and fat-soluble vitamins, so patients need to be counseled on proper timing when taking medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In clinical trials, has the combination of a statin and a resin shown additional cardiovascular risk reduction compared to using either medication alone?

A

No, clinical trials have not demonstrated additional cardiovascular risk reduction by combining a statin and a resin. Using a statin as monotherapy is more effective in reducing cardiovascular morbidity and mortality.

20
Q

Which individuals may be least responsive to statins and resins?

A

Individuals who are homozygous for non-functional LDL receptors (e.g., in familial hypercholesterolemia) may be least responsive to statins and resins, as these drugs rely on the presence and functionality of LDL receptors on the liver to take up cholesterol from the bloodstream.

21
Q

What is a potential serious side effect of statin use, and what should healthcare providers advise patients about this side effect?

A

A potential serious side effect of statin use is myopathy, which can lead to severe muscle pain. Healthcare providers should counsel their patients to contact them if they experience muscle aches. Routine monitoring of liver enzymes for signs of liver toxicity is also recommended.

22
Q

What is the mechanism of action of ezetimibe in lowering LDL cholesterol?

A

Ezetimibe interferes with a transporter responsible for cholesterol uptake in small intestinal cells. By inhibiting this transport, it reduces overall cholesterol levels in the body.

23
Q

How does the efficacy of ezetimibe compare to that of statins in lowering LDL cholesterol?

A

Ezetimibe is less efficacious than statins and typically lowers LDL cholesterol by 15-25%. However, the reduction in LDL cholesterol is a surrogate measure, and clinical trial data have shown that adding ezetimibe to a statin can further lower cholesterol and reduce the risk of cardiovascular adverse events.

24
Q

What is bempedoic acid, and how does it lower cholesterol?

A

Bempedoic acid is an ATP citrate lyase inhibitor indicated for individuals who cannot tolerate statins or need further cholesterol lowering. It inhibits cholesterol synthesis in the liver by blocking the formation of acetyl-CoA.

25
Q

How does bempedoic acid’s mechanism of action compare to that of statins in lowering cholesterol?

A

Bempedoic acid acts two steps upstream of statins, inhibiting cholesterol synthesis. Like statins, it prompts the liver to take up more LDL cholesterol from the bloodstream, reducing cholesterol levels.

26
Q

What are some side effects associated with bempedoic acid?

A

Bempedoic acid’s side effects may include hyperuricemia, gout attacks, and tendon rupture. It is also known to have some drug interactions with specific statins.

27
Q

What are PCSK9 inhibitors, and how do they work to lower LDL cholesterol?

A

PCSK9 inhibitors are monoclonal antibodies that block PCSK9 from binding to LDL receptors. This interference prevents the degradation of LDL receptors, leading to more LDL receptors being present on cell surfaces to remove LDL cholesterol from the bloodstream.

28
Q

What are some key characteristics of PCSK9 inhibitors, such as evolocumab and alirocumab?

A

PCSK9 inhibitors are highly effective, reducing LDL cholesterol by over 60%. They are administered through injections every two or four weeks. Key side effects include injection site pain and swelling. Clinical trials have shown reductions in cardiovascular risk.

29
Q

How does inclisiran, another PCSK9 inhibitor, differ in its mechanism of action from monoclonal antibodies like evolocumab and alirocumab?

A

Inclisiran is an antisense RNA that inhibits the body’s synthesis of PCSK9. This approach reduces the degradation of LDL receptors, similar to monoclonal antibodies. However, clinical trials for its cardiovascular risk reduction are still ongoing.

30
Q

What is a potential side effect of certain cholesterol-lowering drugs, leading to loose stools?

A

Loose stools may result from certain cholesterol-lowering drugs because excess cholesterol leaving the body can affect the gut flora and result in loose stools.

31
Q

What commonality do bempedoic acid and statins share in terms of their mechanisms of action?

A

Both bempedoic acid and statins inhibit cholesterol synthesis in the liver and increase LDL cholesterol uptake by the liver using the LDL receptor.

32
Q

How does niacin lower triglycerides and VLDL particles?

A

Niacin’s mechanism is not fully understood, but it reduces the production of VLDL particles, which primarily carry triglycerides. Niacin affects the components that go into building VLDL particles, leading to lower triglyceride levels.

33
Q

What are some side effects associated with niacin?

A

Niacin may cause flushing, severe GI distress, hepatic toxicity, and worsen insulin resistance. It was the first drug shown to reduce myocardial infarction and overall mortality in patients with coronary heart disease but doesn’t provide additional risk reduction when added to statins.

34
Q

How do fibrates work to lower triglycerides?

A

Fibrates, which activate PPAR-Alpha nuclear receptors, have various effects on lipid metabolism pathways. They reduce the synthesis of triglycerides and increase their removal in the periphery. This leads to a reduction in VLDL particles and triglycerides in the bloodstream.

35
Q

What are some common side effects and potential risks associated with fibrates?

A

Common side effects of fibrates include myopathy, hepatic toxicity, and gallstones. Trials have shown that adding fibrates to statins does not provide additional cardiovascular risk reduction.

36
Q

How do prescription strength fish oil (Omega-3 esters) reduce triglycerides?

A

Fish oil reduces triglycerides by decreasing their synthesis and enhancing their removal. These drugs are prescribed for patients with very high triglyceride levels (over 500 mg/dL).

37
Q

What are some side effects and considerations associated with prescription strength fish oil?

A

Side effects of fish oil may include burping with a fishy smell, upset stomach, and an increased risk of bleeding as they insert in cell membranes. Patients allergic to shellfish should avoid this medication.

38
Q

Which lipid-lowering agents are recommended as first-line treatment?

A

Statins are the first-line treatment due to their oral efficacy and strong evidence from randomized control trials that they significantly reduce cardiovascular risks.

39
Q

What is the general approach when considering adding fibrate or niacin to a statin?

A

Clinical trials have shown that adding fibrate or niacin to a statin does not provide significant additional cardiovascular risk reduction. Therefore, the main initial strategy remains the use of statins, and adding these agents is generally not recommended.

40
Q

What is an important consideration when using cardiovascular risk prediction tools that include race?

A

Race is a social construct and not a proxy for biological properties. When using risk prediction tools that include race, healthcare professionals should critically assess the patient’s individual biology and recommend treatments based on biological factors rather than relying solely on calculations that incorporate race.

41
Q

Your patient TM complains that he has a lot of muscle pain now that he is really following his doctor’s advice of diet, exercise and cholesterol lowering medication after his first heart attack. He tells you that the muscle aches are worse now that he started his new medication. Which of the following lipid lowering drugs can induce muscle pain that in rare cases might progress to rhabdomyolysis if the drug dose is not adjusted?
a. Atorvastatin
b. Colestipol
c. Ezetimibe
d. Fish oil
e. Niacin

A

a. Atorvastatin

42
Q

Your patient TF tells you excitedly that she is trying to become pregnant. You know from her pharmacy record she is on lipid lowering medication. Which of the following drugs will TF need to stop taking because the drug is classified as pregnancy category X?
a. Atorvastatin
b. Ezetimibe
c. Fish oil
d. Niacin

A

a. Atorvastatin

43
Q

Which of the following drugs will have the SLOWEST onset of action, since it involves changes in gene transcription?
a. Atorvastatin
b. Bempedoic Acid
c. Colestipol
d. Ezetimibe
e. Fenofibrate

A

e. Fenofibrate

44
Q

Your patient confides in you that he hates taking his new cholesterol meds because it gives him loose stools and gas. What would be an appropriate response?
a. At your age, loose stools are normal, I don’t think it has anything to do with your drugs
b. Yes that can happen with statins but it is important that you take the meds, you can take loperamide to manage it
c. Yes that can happen with ezetimibe but it is important that you take the med and your body will adjust
d. Yes that can happen with gemfibrozil but it is important that you take the med, you can take loperamide to manage it

A

c. Yes that can happen with ezetimibe but it is important that you take the med and your body will adjust

45
Q

Which of the following lipid lowering drugs lowers BOTH triglycerides and cholesterol?
a. Colestipol
b. Ezetimibe
c. Fenofibrate
d. Fish oil
e. High intensity statins

A

e. High intensity statins